MedTrace Logo

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

NCT00148902 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2017-12-06

No results posted yet for this study

Summary

This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).

Conditions

  • Neoplasms, Breast

Interventions

DRUG

lapatinib

lapatinib

DRUG

docetaxel

docetaxel

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-28
Primary Completion
2006-01-21
Completion
2006-01-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00148902 on ClinicalTrials.gov